The 3q29 Deletion and 3q29 Duplication: Architecture of Behavioral Phenotypes
Rutgers, The State University of New Jersey · NCT02447861
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Any age listed · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 800
- US sites recruiting
- 1
- Study start
- July 2013
- Record last updated
- May 20, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The 3q29 deletion syndrome is caused by a deletion of a small part of human chromosome 3, and the duplication syndrome is caused by a duplication of this same small region. The purpose of this study is to understand the medical and behavioral consequences of these syndromes.
Conditions: Microdeletion 3q29 Syndrome; Microduplication 3q29 Syndrome
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Diagnosis of 3q29 deletion or 3q29 duplication
- Consent from parents or guardians or an adult with 3q29 deletion or 3q29 duplication that does not require a legal guardian or an adult who is the healthy sibling of an individual with 3q29 deletion or 3q29 duplication or a healthy age-matched control
Exclusion Criteria
- Clinically significant medical disease that would prohibit participation in the study procedures
Recruiting US locations
Internet-Based
Piscataway, NJ 08854
Site contact: Jennifer Mulle, MHS, PhD · (848) 445-9866 · jennifer.mulle@rutgers.edu
Study contacts (from the official record)
- Jennifer G Mulle, MHS, PhD · (848) 445-9866 · jennifer.mulle@rutgers.edu
- Teresa Irving · tmi21@cabm.rutgers.edu
Similar studies in New Jersey
All healthy volunteers studies in New Jersey →- RecruitingHealthy volunteersPhase 1
Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
Arcutis Biotherapeutics, Inc.
- Location
- Fair Lawn, NJ + 6 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Clinical Trial of MK-1406 in Healthy Participants (MK-1406-008)
Merck Sharp & Dohme LLC
- Location
- Marlton, NJ + 5 other US sites
- Eligibility basics
- Ages 18–64
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Jersey City, NJ + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
Study of Single Doses of HBS-104 in Acutely Sleep-deprived Healthy Participants
Harmony Biosciences Management, Inc.
- Location
- Eatontown, NJ
- Eligibility basics
- Ages 18–55